BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26473809)

  • 1. A Promising PET Tracer for Imaging of α₇ Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based Radioligand.
    Teodoro R; Scheunemann M; Deuther-Conrad W; Wenzel B; Fasoli FM; Gotti C; Kranz M; Donat CK; Patt M; Hillmer A; Zheng MQ; Peters D; Steinbach J; Sabri O; Huang Y; Brust P
    Molecules; 2015 Oct; 20(10):18387-421. PubMed ID: 26473809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivatives of dibenzothiophene for positron emission tomography imaging of α7-nicotinic acetylcholine receptors.
    Gao Y; Kellar KJ; Yasuda RP; Tran T; Xiao Y; Dannals RF; Horti AG
    J Med Chem; 2013 Oct; 56(19):7574-89. PubMed ID: 24050653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
    Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [
    Donat CK; Hansen HH; Hansen HD; Mease RC; Horti AG; Pomper MG; L'Estrade ET; Herth MM; Peters D; Knudsen GM; Mikkelsen JD
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32245032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements.
    Ettrup A; Mikkelsen JD; Lehel S; Madsen J; Nielsen EØ; Palner M; Timmermann DB; Peters D; Knudsen GM
    J Nucl Med; 2011 Sep; 52(9):1449-56. PubMed ID: 21828113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging of α
    Hillmer AT; Li S; Zheng MQ; Scheunemann M; Lin SF; Nabulsi N; Holden D; Pracitto R; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Esterlis I; Cosgrove KP; Brust P; Carson RE; Huang Y
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1042-1050. PubMed ID: 28120003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
    Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
    J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of new imaging agent for central nicotinic acetylcholine receptor α7 subtype.
    Ogawa M; Nishiyama S; Tsukada H; Hatano K; Fuchigami T; Yamaguchi H; Matsushima Y; Ito K; Magata Y
    Nucl Med Biol; 2010 Apr; 37(3):347-55. PubMed ID: 20346874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An experimental study on (131)I-CHIBA-1001: a radioligand for α7 nicotinic acetylcholine receptors.
    Yin L; Zhao Q; Li L; Zhang SL; Chen XQ; Ma C; Kang L; Liu M; Zhang CL; Yan P; Wang RF
    PLoS One; 2013; 8(7):e70188. PubMed ID: 23936161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PET.
    Horti AG; Gao Y; Kuwabara H; Wang Y; Abazyan S; Yasuda RP; Tran T; Xiao Y; Sahibzada N; Holt DP; Kellar KJ; Pletnikov MV; Pomper MG; Wong DF; Dannals RF
    J Nucl Med; 2014 Apr; 55(4):672-7. PubMed ID: 24556591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.
    Hansen HD; Herth MM; Ettrup A; Andersen VL; Lehel S; Dyssegaard A; Kristensen JL; Knudsen GM
    J Nucl Med; 2014 Apr; 55(4):640-6. PubMed ID: 24566002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [
    Vetel S; Vercouillie J; Buron F; Vergote J; Tauber C; Busson J; Chicheri G; Routier S; Sérrière S; Chalon S
    Mol Imaging Biol; 2020 Apr; 22(2):348-357. PubMed ID: 31286348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole.
    Tipre DN; Zoghbi SS; Liow JS; Green MV; Seidel J; Ichise M; Innis RB; Pike VW
    J Nucl Med; 2006 Feb; 47(2):345-53. PubMed ID: 16455642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
    Saigal N; Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2006 Oct; 47(10):1697-706. PubMed ID: 17015907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.
    Ravert HT; Dorff P; Foss CA; Mease RC; Fan H; Holmquist CR; Phillips E; McCarthy DJ; Heys JR; Holt DP; Wang Y; Endres CJ; Dannals RF; Pomper MG
    Nucl Med Biol; 2013 Aug; 40(6):731-9. PubMed ID: 23680470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIDA522131, a new radioligand for imaging extrathalamic nicotinic acetylcholine receptors: in vitro and in vivo evaluation.
    Chefer SI; Pavlova OA; Zhang Y; Vaupel DB; Kimes AS; Horti AG; Stein E; Mukhin AG
    J Neurochem; 2008 Jan; 104(2):306-15. PubMed ID: 17986233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Availability of the α7-Nicotinic Acetylcholine Receptor in Brains of Individuals with Mild Cognitive Impairment: A Pilot Study Using
    Coughlin JM; Rubin LH; Du Y; Rowe SP; Crawford JL; Rosenthal HB; Frey SM; Marshall ES; Shinehouse LK; Chen A; Speck CL; Wang Y; Lesniak WG; Minn I; Bakker A; Kamath V; Smith GS; Albert MS; Azad BB; Dannals RF; Horti A; Wong DF; Pomper MG
    J Nucl Med; 2020 Mar; 61(3):423-426. PubMed ID: 31420499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter.
    Sorger D; Scheunemann M; Grossmann U; Fischer S; Vercouille J; Hiller A; Wenzel B; Roghani A; Schliebs R; Brust P; Sabri O; Steinbach J
    Nucl Med Biol; 2008 Feb; 35(2):185-95. PubMed ID: 18312828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosynthesis of (S)-[
    Sarasamkan J; Fischer S; Deuther-Conrad W; Ludwig FA; Scheunemann M; Arunrungvichian K; Vajragupta O; Brust P
    Appl Radiat Isot; 2017 Jun; 124():106-113. PubMed ID: 28365525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 18F-labeled benzodioxine piperazine-based dopamine D4 receptor ligands: lipophilicity as a determinate of nonspecific binding.
    Kügler F; Sihver W; Ermert J; Hübner H; Gmeiner P; Prante O; Coenen HH
    J Med Chem; 2011 Dec; 54(24):8343-52. PubMed ID: 22039961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.